Kenichi Harada
Impact in
- Hepatology top 0.2%
- Liver Diseases and Immunity
- Rheumatology top 0.2%
- IgG4-Related and Inflammatory Diseases
Papers in
- Hepatology 134
- Liver Diseases and Immunity 95
- Liver physiology and pathology 29
- Surgery 173
- Cholangiocarcinoma and Gallbladder Cancer Studies 75
- Pediatric Hepatobiliary Diseases and Treatments 73
- Co-authors
- Yasuni NakanumaYasunori SatoMotoko SasakiYoh ZenKoichi TsuneyamaKumiko IsseSatoru OzakiShinji Shimoda
- Journals
- Hepatology (21 papers)Hepatology Research (20 papers)Pathology International (19 papers)Human Pathology (16 papers)American Journal Of Pathology (13 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Kenichi Harada
319 papers receiving 9.4k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Hepatology 3.2k
- Rheumatology 1.8k
- Surgery 4.9k
- Epidemiology 3.3k
- Oncology 1.9k
Countries citing papers authored by Kenichi Harada
This map shows the geographic impact of Kenichi Harada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenichi Harada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenichi Harada more than expected).
Fields of papers citing papers by Kenichi Harada
This network shows the impact of papers produced by Kenichi Harada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenichi Harada. The network helps show where Kenichi Harada may publish in the future.
Co-authors
The 25 scholars most cited alongside Kenichi Harada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 38 | |
| 10 | 2022 | 14 | |
| 11 | 2022 | 29 | |
| 12 | 2022 | 34 | |
| 13 | 2022 | 19 | |
| 14 | 2020 | 14 | |
| 15 | 2019 | 23 | |
| 16 | Different carcinogenic process in cholangiocarcinoma cases epidemically developing among workers of a printing company in Japan. | 2014 | 29 |
| 17 | 2013 | 27 | |
| 18 | Biliary innate immunity: Function and modulation | 2010 | 50 |
| 19 | 2007 | 22 | |
| 20 | Intrahepatic bile duct loss in immune-mediated ductopenic biliary diseases with an emphasis on biliary epithelial apoptosis. | 2003 | 3 |
About Kenichi Harada
Kenichi Harada is a scholar working on Hepatology, Surgery, Epidemiology, Oncology and Rheumatology, having authored 334 papers that have together received 9.6k indexed citations. Recurring topics across this work include Liver Diseases and Immunity (95 papers), Liver Disease Diagnosis and Treatment (78 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (75 papers), Pediatric Hepatobiliary Diseases and Treatments (73 papers), Liver physiology and pathology (29 papers), Pancreatic and Hepatic Oncology Research (28 papers), IgG4-Related and Inflammatory Diseases (27 papers) and Genetic and Kidney Cyst Diseases (21 papers). The work is most often cited by research in Hepatology (3.2k citations), Rheumatology (1.8k citations), Surgery (4.9k citations), Epidemiology (3.3k citations) and Oncology (1.9k citations). Kenichi Harada has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Yasuni Nakanuma, Yasunori Sato, Motoko Sasaki, Yoh Zen, Yasuni Nakanuma, Koichi Tsuneyama, Kumiko Isse, Satoru Ozaki, Shinji Shimoda and M. Eric Gershwin. Their work appears in journals such as Hepatology, Hepatology Research, Pathology International, Human Pathology and American Journal Of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.